Previous Article | Next Article ![]()
Infection and Immunity, August 2001, p. 5107-5114, Vol. 69, No. 8
ZAP Laboratories, Department of Veterinary
Pathology, University of Edinburgh, Edinburgh,1
and Department of Medical Microbiology, University of Aberdeen,
Aberdeen,2 United Kingdom, and Institut
für Medizinische Mikrobiologie,
Justus-Leibig-Universität, Giessen,
Germany3
Received 27 November 2000/Returned for modification 28 February
2001/Accepted 3 May 2001
Ongoing extensive epidemiological studies of verotoxin-carrying
Escherichia coli O157
(stx+
eae+) have shown this
bacterial pathogen to be common in cattle herds in the United States
and the United Kingdom. However, the incidence of disease in humans due
to this pathogen is still very low. This study set out to investigate
if there is a difference between strains isolated from human disease
cases and those isolated from asymptomatic cattle which would account
for the low disease incidence of such a ubiquitous organism. The work
presented here has compared human disease strains from both sporadic
and outbreak cases with a cross-section, as defined by pulsed-field gel
electrophoresis, of E. coli O157 strains from cattle.
Human (n = 22) and bovine (n = 31) strains were genotyped for carriage of the genes for Shiga-like
toxin types 1, 2, and 2c; E. coli secreted protein genes
espA, espB, and espP; the enterohemolysin
gene; eae (intimin); ast
(enteroaggregative E. coli stable toxin [EAST]); and
genes for common E. coli adhesins. Strains were
also phenotyped for hemolysin, EspP, Tir, and EspD expression as well
as production of actin and cytoskeletal rearrangement associated
with attaching and effacing (A/E) lesions on HeLa cells. The genotyping
confirmed that there was little difference between the two groups,
including carriage of stx2 and
stx2c, which was similar in both sets.
ast alleles were confirmed to all contain mutations that
would prevent EAST expression. espP mutations were found
only in cattle strains (5 of 30). Clear differences were observed in
the expression of locus of enterocyte effacement (LEE)-encoded factors
between strains and in different media. EspD, as an indicator of LEE4
(espA, -B, and -D) expression, and Tir
levels in supernatants were measured. Virtually all strains from both
sources could produce EspD in Luria-Bertani broth, although at very
different levels. Standard trichloroacetic acid precipitation of
secreted proteins from tissue culture medium produced detectable levels
of EspD from the majority of strains of human origin (15 of 20)
compared with only a few (4 of 20) bovine strains
(P < 0.001), which is indicative of much higher
levels of protein secretion from the human strains. Addition of bovine
serum albumin carrier protein before precipitation and enhanced
detection techniques confirmed that EspD could be detected after growth
in tissue culture medium for all strains, but levels from strains
of human origin were on average 90-fold higher than those from strains
of bovine origin. In general, levels of secretion also correlated
with ability to form A/E lesions on HeLa cells, with only the
high-level protein secretors in tissue culture medium exhibiting a
localized adherence phenotype. This research shows significant
differences between human- and bovine-derived E. coli O157 (stx+
eae+) strains and their production of
certain LEE-encoded virulence factors. These data support the recent
finding of Kim et al. (J. Kim, J. Nietfeldt, and A. K. Benson,
Proc. Natl. Acad. Sci. USA 96:13288-13293, 1999) proposing
different E. coli O157 lineages in cattle and humans and
extend the differential to the regulation of virulence factors.
Potentially only a subset of E. coli O157 isolates
(stx+
eae+) in cattle may be capable of
causing severe disease in humans.
Enterohemorrhagic Escherichia
coli (EHEC) strains are a class of pathogenic E. coli
strains that are associated with hemorrhagic colitis and hemolytic
uremic syndrome in humans (34). There are several
different serotypes of EHEC, with E. coli O157 being the
major pathogen in humans, particularly in the United States and the
United Kingdom. Recent epidemiological studies have shown a high
prevalence of this organism in cattle and their environment (18,
40), but the level of human infection remains relatively low (2 to 6 of 100,000) (21, 36). One possible explanation for
this is a difference in the human-pathogenic potential between strains
of bovine origin. A recent study has proposed different lineages for
bovine and human strains based on octamer genome scanning
(27), but this did not include analysis of virulence factors. EHEC strains isolated from human disease cases have been characterized for virulence determinants (3, 9, 45), as have bovine Shiga toxin-positive E. coli O157 strains
(8, 14, 20, 41). The few studies that have compared human
and bovine strains for carriage of virulence determinants have not
found notable differences (7, 13, 33).
EHEC stains are similar to enteropathogenic E. coli (EPEC)
strains in that they produce characteristic attaching and effacing (A/E) lesions in experimental infections and in vitro assays, the
formation of which is dependent on the locus of enterocyte effacement
(LEE) pathogenicity island (32). Genes found on the LEE
include the genes encoding the adhesion molecule intimin
(eae) and its receptor (tir), a type III
secretion system, and the LEE effector molecules (espA,
espB, and espD) (35). It is thought that after initial attachment to the host cell, type III secretion of
Tir through an EspA filament and EspB-EspD pore (translocon) facilitates intimate attachment of the bacterium via intimin and Tir
(23). Continued production and secretion of LEE-encoded proteins (including Tir, EspB, and EspD) leads to host cell actin rearrangement and the formation of A/E lesions (25, 30).
Other virulence factor genes found on the EHEC chromosome include those
encoding the Shiga toxins Stx1 and Stx2 and variants (stx1, stx2,
and stx2c). For example, hemolytic uremic
syndrome is associated with stx2 and
stx2c carriage (8).
stx genes are located on lysogenic phages. Their
transmissibility has led to EHEC strains containing different
combinations of Stx variants. Also found on the chromosome of EHEC
strains are two copies of the astA gene (39),
potentially encoding a small heat-stable enterotoxin known as EAST.
Recent research has indicated that both copies of astA are
unlikely to be expressed (43). EHEC strains also contain a
97-kb plasmid, pO157, that carries a number of genes, the products of
which may be associated with virulence (12). These include
an enterohemolysin gene (ehx), an immunomodulator gene
(lif) (28), and espP, encoding a
member of the SPATE (for serine protease autotransporters of
Enterobacteriaceae) family (1). Consequently,
the pathogenesis of EHEC strains is likely to be complex and
multifactorial (37).
In this study human disease and bovine fecal E. coli O157
strains were screened for a range of virulence determinants, including toxins and adhesins. Secreted protein profiles of strains were analyzed, including specific detection of Tir, EspD, and EspP. Host
cell actin rearrangement by fluorescent actin staining (FAS) was also
investigated. The results showed that while genotypic heterogeneity was
mainly confined to carriage of stx variants and
espP alleles, there was considerable strain- and
medium-dependent variation in EspD and Tir secretion levels. Esp
secretion levels correlated with the extent of A/E lesion formation,
including the localized adherence phenotype. Strains of human origin
produced significantly higher levels of EspD in tissue culture medium
than the majority of cattle strains. Therefore, the human-pathogenic potential of bovine E. coli O157 strains may be linked to
not only Shiga-like toxin expression but also to variation in the regulation and expression of other virulence-associated factors.
Bacterial strains.
Thirty EHEC strains of serotype
O157 and 1 of serotype O26 from human disease cases as well as 30 strains of serotype O157 isolated from asymptomatic cattle were
obtained from the Scottish E. coli Reference Laboratory.
ZAP001, -004, -008, -010, -026, -058 to -089, and -104 to -112 are
human disease O157 strains. ZAP021 (bovine diarrhea) and ZAP078 (human
disease) are O26 strains. ZAP028 to -057 are bovine E. coli
O157 strains. The bovine strains used in this study represent all
common variations in pulsed-field gel electrophoresis (PFGE) and phage
type profiles found among E. coli O157 strains present in
Scotland between 21 June 1999 and 16 November 1999. The PFGE methods
used were described by Allison et al. (2). Their PFGE
macrorestriction profiles differ by one to eight fragments; 24 of
30 bovine isolates differed by two or more PFGE fragments (two to eight
fragment differences), and 16 of 30 differed by three or more fragments
(data not shown). The human disease-associated strains were isolated
from both major and sporadic outbreaks in Scotland over a 6-year period
at the reference center. EPEC strain E2348/69 was supplied by Brendan Kenny, University of Bristol. All strains were stored on Protech beads
at PCR detection of genes encoding secreted proteins.
All
primer sequences used are shown in Table
1. For bacterial lysates, a colony was
suspended in 100 µl of sterile phosphate-buffered saline (PBS) and
boiled for 10 min. Lysates were stored at
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.8.5107-5114.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Differences in Levels of Secreted Locus of
Enterocyte Effacement Proteins between Human Disease-Associated and
Bovine Escherichia coli O157
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
70°C in Luria-Bertani (LB) broth with 20% glycerol. For all
experiments the strains were initially plated out on Columbia agar with
10% horse blood (Oxoid, Basingstoke, United Kingdom).
20°C. All PCRs were
carried out in 50-µl reaction volumes containing 2 µl of bacterial
lysate, 200 µmol of deoxynucleotide mix (dATP, dTTP, dCTP, and dGTP),
100 pmol of each primer, 5 µl of 10× PCR buffer with 1.5 mM
MgCl2, and 2.5 U of Taq DNA polymerase
(Roche Diagnostics). stx PCR and restriction fragment length
polymorphism (RFLP) were carried out as previously described using the
Lin-all system (4), as was the ehx PCR
(20). The eae PCR was performed as described
previously (22). The primers for detection of
espA and espB (Table 1) were designed from the
sequence of the E. coli O157 EDL933 LEE (35).
Cycling conditions were denaturation at 94°C for 45 s, annealing
at 57°C for 45 s, and extension at 72°C for 90 s for 30 cycles, with a final extension at 72°C for 10 min. Primers for
detection of the astA gene were designed from the
astA gene sequenced from enteroaggregative E. coli (42). EASTa and EASTb were designed to
amplify a 172-bp region encompassing the entire coding sequence plus
adjacent sequence. Cycling conditions were denaturation at 94°C for
45 s, annealing at 55°C for 45 s, and extension at 72°C
for 90 s for 30 cycles, with a final extension at 72°C for 10 min. Primers for detection of the lif gene and the
espP gene were designed from the entire pO157 sequence
(12). LIFa and LIFb were designed to amplify a 330-bp
region of the N-terminal conserved region of the projected Lif protein.
Cycling conditions were denaturation at 94°C for 45 s, annealing
at 51°C for 45 s, and extension at 72°C for 90 s for 30 cycles, with a final extension at 72°C for 10 min. ESPPa and ESPPb
were designed to amplify a 301-bp N-terminal region of the
espP gene. Cycling conditions were denaturation at 94°C
for 45 s, annealing at 59°C for 45 s, and extension at
72°C for 90 s for 30 cycles, with a final extension at 72°C
for 10 min.
TABLE 1.
Oligonucleotide primers used in this study
PCR detection of genes encoding E. coli adhesins. A range of E. coli adhesins were screened for by PCR (Table 1). The adhesins were as follows: type 1 pili, which are found in approximately 90% of all E. coli strains; K88 (F4) antigen, which is found in E. coli serotypes associated with disease in pigs; K99 (F5) antigen, which is found in calf enterotoxigenic E. coli strains; the F17 fimbrial family, including F17a, F17b, F17c, and F111 fimbriae produced by bovine E. coli strains; the F41 fimbrial family, which are also found in calf enterotoxigenic E. coli strains; F107 adhesins, which have been reported as porcine colonization factors; and S and P family adhesins. These were detected using primers designed at the Institute for the Molecular Biology of Infectious Disease, Wurzburg, Germany (Table 1).
Plasmid extraction and Southern blotting. The large virulence plasmid pO157 was isolated with a Midi-prep spin kit (Qiagen) using the manufacturer's protocol for low-copy-number plasmids.
Plasmids were digested with BamHI (New England Biolabs), and the digested DNA was separated in a 0.7% agarose gel. The DNA was transferred to a nylon membrane and UV cross-linked. Hybridization was performed using the digoxigenin-11-deoxyuridine triphosphate (DIG) DNA labeling and detection kit (Roche Diagnostics) according to the manufacturer's instructions. Briefly, an espP gene probe was prepared by incorporating DIG during the espP PCR described above. The PCR product was purified with the QIAquick PCR purification kit (Qiagen), and the probe was hybridized to a membrane at 68°C. The hybridized probe was detected using alkaline phosphatase-labeled anti-DIG antibody according to the manufacturer's instructions.Sequence analysis. For sequencing, the PCR products were purified using a Qiagen PCR purification kit and cloned into pCR4-TOPO using the TOPO-TA cloning kit (Invitrogen BV, Groningen, The Netherlands) according to the manufacturer's instructions. Sequence analysis and sequence alignments were carried out using the Vector NTi and AlignX programs (Informax, Oxford, United Kingdom). Sequence analysis of the PCR products was performed in each case using two clones.
Protein precipitation. Bacteria were grown in LB broth or minimum essential medium (MEM) with 25 mM HEPES (Sigma-Aldrich, Dorset, United Kingdom) to an optical density at 600 nm of 0.9. Suspensions were centrifuged at 4,000 × g for 10 min. The supernatants were filtered, and the proteins were precipitated by the addition of 10% (vol/vol) trichloroacetic acid (TCA) with overnight incubation at 4°C. Precipitates underwent subsequent centrifugation at 4,000 × g for 30 min at 4°C. The protein pellet was dried and suspended in 1.5 M Tris (pH 8.8), and after addition of sample buffer, the proteins were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and silver staining. In order to compare protein levels in supernatants and to rule out the precipitation procedure as a source of variation, bovine serum albumin (BSA) (1 µg/ml) was added in certain cases to supernatants prior to precipitation.
Detection of protein expression. Protein samples were separated by SDS-PAGE and blotted onto a Hybond ECL nitrocellulose membrane (Amersham Pharmacia Biotech, Bucks, United Kingdom) using a mini Trans-blot electrophoretic transfer cell (Bio-Rad, Herts, United Kingdom). After blocking overnight, membranes were incubated for 3 h with monoclonal antibody (anti-EspD, -P, and -Tir) at a dilution of 1:75 (14, 15). Membranes were washed three times and then incubated for 2 h with horseradish peroxidase-conjugated goat anti-mouse immunoglobulin secondary antibody (Dako, Cambridge, United Kingdom) at a dilution of 1:750. Bound antibody was visualized after 5 min of incubation with a 1:1 mixture of Pierce (Rockford, Ill.) Luminol enhancer solution and Pierce Stable Peroxide solution. Relative levels of EspD were determined by quantifying luminescence using a Flowgen MultiImage cabinet and MultiImage Spot densitometer software (Flowgen, Staffs, United Kingdom).
A/E lesion formation assay. Bacterial adhesion and fluorescence staining of actin were performed as previously described (29). Briefly, subconfluent cultures of HeLa cells on glass coverslips were placed in the wells of a multiwell tissue culture plate with 1 ml of MEM and 10% fetal calf serum. Bacteria were grown in LB broth overnight at 37°C, and then a 1:50 dilution was made of the culture in MEM, which was incubated at 37°C with shaking to an optical density at 600 nm of 0.5. MEM was removed from tissue culture cells, and 1 ml of a 1:500 dilution of the bacterial culture was added to the cells. The mixture was centrifuged at 2,000 × g for 5 min and incubated at 37°C in 5% CO2 for 5 h. Fresh medium was added after 3 h. After incubation, cells were washed three times in PBS to remove nonadherent bacteria, fixed in 4% formalin for 20 min, and then permeabilized with 0.1% Triton X-100 in PBS for 5 min. After three washes in PBS, coverslips were treated with a 5-µg/ml solution of fluorescein isothiocyanate-phalloidin (Sigma-Aldrich) in PBS to specifically stain actin filaments. Bacteria were counterstained using anti-O157/O26 primary antibody (MAST Diagnostics, Merseyside, United Kingdom) and a tetramethyl rhodamine isocyanate-labeled anti-rabbit immunoglobulin secondary antibody (Dako). Coverslips were washed three times in PBS and examined by fluorescence and phase-contrast microscopy using a Leica DMLB fluorescence microscope. HeLa cells with no bacteria added were fixed, permeabilized, and stained as a negative control for each assay.
| |
RESULTS |
|---|
|
|
|---|
Adhesin profiling. A broad range of common adhesins associated with pathogenic E. coli were screened for by PCR in the two sets of strains. All strains tested negative for all of the adhesin genes assayed (F4, F5, F17, F41, F107, and P and S fimbriae), with the exception of the fim switch region (type 1 fimbriae). All E. coli O157 strains contained the fim switch, but with a 16-bp deletion in the switch region (38). A primer bridging this deletion has been previously identified as very effective in defining the presence of E. coli O157 by PCR (31).
LEE gene carriage. The presence of three of the genes found on the LEE pathogenicity island, eae, espA, and espB, was assayed by PCR. Fifty of 53 strains tested positive for all three, indicating that these strains carry the LEE pathogenicity island. All strains tested were positive for eae, with only three strains being negative for both espA and espB. All negative tests were repeated for confirmation.
stx genotype.
The stx genotypes of
51 EHEC O157 strains were investigated by PCR and RFLP
(4). Results were based on duplicate reactions. Seventeen
out of 21 human EHEC O157 strains carried a
stx2 or stx2c
gene (or both). Of the 30 bovine EHEC O157 strains, 29 carried a
stx2 or stx2c
gene (or both). Six of 21 human strains contained stx1, a total similar to that for the
bovine strains (8 of 30) (Table 2). This
is in contrast to a similar study in Germany of E. coli O157
strains, which showed a correlation between bovine strains and carriage
of stx1 and espP
(11). When carriage of various combinations of the
stx1, stx2, and
stx2c genes was examined, there appeared to
be no clear differences between bovine and human strains (Table 2).
|
Analysis of espP, ehx,
lif, and astA.
All human EHEC
strains (21 serotype O157 strains and 1 serotype O26 strain) carried
espP, ehx, lif, and astA.
Examples of the agarose gels obtained for these PCRs are shown in Fig.
1. Certain genes were not detected in
some strains: five of the bovine strains tested negative for
espP, three tested negative for ehx, and one
tested negative for astA. All negative PCRs were confirmed. All 31 bovine strains (30 serotype O157 strains and 1 serotype O26
strain) carried lif. Of the 53 strains assayed, only the 3 strains negative by PCR for ehx did not exhibit hemolysis on
Columbia agar plates containing 10% horse blood.
|
LEE protein secretion.
Proteins present in the supernatants of
30 EHEC strains, 15 human and 15 bovine, were TCA precipitated and
visualized by SDS-PAGE on a 12.5% polyacrylamide gel by silver
staining. There was considerable variation in the levels of protein
present, both between strains and when the same strains were cultured
in different media, i.e., LB broth and MEM (data not shown). Detection
of specific factors (EspP, EspD, and Tir) was carried out by Western
blotting on 24 of these strains (11 human E. coli O157, 1 human E. coli O26, 11 bovine E. coli O157, and 1 bovine E. coli O26). Importantly, both human and cattle
strains secreted similar amounts of EspP when cultured in LB broth
(Fig. 2). This demonstrated that the preparation and loading of the secreted protein samples allowed for
valid comparison of protein levels in the LB supernatants between
strains (Fig. 2). In LB broth virtually all the strains analyzed
demonstrated secretion of EspD by Western blotting, although at very
different levels. Tir could also be detected from the majority of
strains in LB broth, although again at very different levels, with
overexposure of blots being required to detect its expression in lanes
apparently negative in Fig. 2 (data not shown).
|
|
A/E lesion formation.
A subset of 16 strains (8 bovine and 8 human) from the 24 examined initially for EspD and Tir secretion were
also analyzed for their ability to induce actin and cytoskeletal
rearrangements in HeLa cell monolayers. Actin rearrangement was
determined by FAS, and colocalization of bacteria was carried out via
anti-LPS (O157 or O26 as appropriate) primary and tetramethyl rhodamine isocyanate secondary antibody binding (29). The
strains were compared by determining the number of HeLa cells
displaying actin aggregation at sites of bacterial attachment
5 h postinoculation (Table 3; Fig.
4). All 16 strains assayed were able to
stimulate some degree of actin aggregation in comparison to the
negative control. However, the strains varied considerably in the
number of foci and the level to which they stimulated these
rearrangements, i.e., in localized adherence (LA) versus diffuse
adherence (DA) (Table 3; Fig. 4). The strains that formed detectable
lesions in the highest percentage of host cells also could display the LA phenotype (Table 3). In turn, this activity correlated well with
high-level EspD secretion in MEM.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The aim of this study was to establish whether differences in virulence determinant carriage or expression could be detected between E. coli O157 strains isolated from cattle and those from outbreaks of human disease. The 53 bovine and human strains analyzed were selected because they encompass the major variations in PFGE profiles observed in Scotland as determined by the Scottish E. coli O157 reference laboratory. Obvious differences were detected in the level of secretion of LEE-encoded factors between strains and in different media. Human strains produced significantly higher levels of secreted proteins in MEM, as measured by blotting of EspD. A/E lesion formation and actin rearrangement potential correlated with this finding. If A/E lesion formation is an important part of the virulence of EHEC O157, then bovine strains may differ in their human-pathogenic potential.
The majority of our strains produced high levels of supernatant proteins when grown in LB broth; however, there was considerable variation between the strains in levels of LEE-secreted protein production in this medium. This was determined by Western blotting of EspD and Tir. SepL and EspA, -B, and -D are transcribed from the same promoter, and therefore EspD expression may reflect that of EspA and EspB. Tir is transcribed with intimin and a protein of unknown function, so Tir secretion may also be indicative of intimin production (5, 24). In LB broth, while there was considerable variation in secretion levels between strains, the strain-specific levels of EspD and Tir were always related, and all strains except ZAP034 and ZAP041 could produce both proteins, although Tir production from the majority of bovine strains examined was only just detectable. Technical considerations were ruled as an explanation of these differences, as the EspP levels detectable in the secreted protein preparations were very consistent.
The pattern of EspD and Tir secretion changed significantly when the strains were cultured in MEM, which has been shown to lead to maximal LEE protein secretion (5, 17). Standard TCA precipitation and Western blotting detected EspD from 15 of 20 human E. coli O157 strains compared to 4 of 20 bovine E. coli O157 strains (P < 0.001) (Fig. 2). The levels of secreted proteins in the supernatants of negative strains were so low that it could prevent effective precipitation. Only through addition of BSA carrier protein and use of a more sensitive detection technique could EspD be detected in all supernatants. Comparison of EspD levels from the two sets of strains confirmed much higher expression levels (average of 90-fold) from the human strains. This difference could also apply to other proteins expressed from the same operon (EspA and EspB). Also, in MEM, Tir could not usually be detected, with only 4 of 22 strains (2 E. coli O157 and 2 E. coli O26 strains) giving detectable levels of Tir, and those strains producing high levels of EspD in MEM did not necessarily produce detectable Tir. Therefore, with two exceptions (one O157 strain and one O26 strain), Tir secretion did not appear to be enhanced by growth in MEM rather than LB medium as reported previously (15); however, shaking as opposed to static cultures were used in our study. These results demonstrate that there are marked differences in production of EHEC LEE proteins between EHEC O157 strains and in different media. In the case of EspD secretion in MEM, there was a positive correlation between this ability and isolation of strains from cases of human disease.
In order to examine whether these protein secretion differences affect the strains' ability to induce cytoskeletal rearrangements, 16 strains were tested for A/E lesion formation with HeLa cells. The strains could be grouped into two categories: those that could form obvious microcolonies with evident actin rearrangement (LA) or those that adhered diffusely (DA) but still induced rearrangement (Fig. 4). The LA phenotype correlated with those strains that also induced A/E lesions in the highest proportion of host cells (Table 3). Furthermore, these strains (with one exception, ZAP032) were also high-level producers of EspD in MEM. Presumably these strains would also express EspA and -B at higher levels. Therefore, the bovine strains examined, while filling the usual criteria for pathogenic potential (stx and eae positive), demonstrated marked variation in LEE-encoded factor expression that correlated with the potential to form A/E lesions. While the majority of strains analyzed could express LEE-encoded factors under certain conditions, the regulation of these factors differed between strains. These regulatory differences, highlighted by EspD expression in MEM, may indicate the human-pathogenic potential of a strain. Recent work (19) has shown that a pivotal regulator of LEE-encoded factors is Ler (LEE-encoded regulator), and our ongoing work is assessing whether changes in the activity of this regulator could account for the different expression profiles detected in this study.
In contrast to the results of the phenotypic analyses, there appeared to be very few genotypic differences between these two subsets which could account for pathogenic potential. Most of the human disease strains (except serotype O26) carried a stx2 or stx2c gene, as has been reported previously (9). The percentages of bovine strains carrying either of these genes was also very high (Table 2), with only one bovine strain being negative for a stx2 variant. The percentage of strains carrying stx1 was also similar for bovine and human strains (Table 2), in contrast to the case in other countries, where EHEC strains in cattle tend to carry stx1 (9).
There was little or no heterogeneity in carriage of the other toxins or virulence-associated determinants. All strains were negative for genes encoding F4, F5, F17, F41, F107, and P and S fimbriae. fim (type 1 fimbriae) was detected by PCR in all strains but is not expressed by EHEC O157 (31, 38). Almost all strains tested carried genes encoding enterohemolysin, EAST, EspP, Lif, intimin, EspA, and EspB, consistent with the presence of the LEE and pO157. astA (EAST) has been detected in different types of diarrheagenic E. coli (44), including on the chromosome of E. coli O157 in two copies (39). Recent work has identified two types of mutated astA genes in E. coli O157, a 24-bp deletion of the first 8 codons of the gene coding sequence and a single base substitution in the ATG start codon, distributed among strains (43). In this study, the presence of one or both mutated alleles was confirmed in a number of strains, including O157, O26, and the prototype EPEC strain E2348/69. Most EHEC strains appear to contain two copies of the gene, as previously documented (39). Therefore EAST will not be produced by EHEC O157 and is not a functional toxin in EHEC pathogenesis.
All of the human strains produced EspP, whereas six of the bovine strains did not. Five of these were also negative by PCR, and while they were confirmed as possessing espP sequence on pO157 by Southern blotting, their RFLP patterns showed a deletion in the espP region. These five strains contain a 1.4-kb deletion occurring at the 5' end of the gene that has been previously reported (10). It is of interest that in our study, all of the strains containing a mutated espP gene were bovine strains (5 of 30). Therefore, in this study, expression of this factor does appear to correlate with human disease. The role of EspP in EHEC pathogenesis and production of the protein in human disease and during bovine colonization merits further investigation. Indeed, recent work has shown that mutation in a SPATE-encoding gene led to decreased virulence in animal models by interfering with colonization of the intestine (see Discussion in reference 26).
Recent studies have shown that E. coli O157 is prevalent in cattle and their environment (18, 40). However, the incidence of human infection with this organism is still relatively low. This study has identified for the first time clear differences between E. coli O157 (stx+ eae+) strains in their ability to express virulence-associated factors. In addition, there is a positive correlation between strains of human origin and high-level expression of EspD in tissue culture medium. This expression pattern was observed in only a minority of bovine strains and may be an indicator of human-pathogenic potential.
| |
ACKNOWLEDGMENTS |
|---|
This research was supported by a Ministry of Agriculture Fisheries and Food Research program grant to D.L.G and D.G.E.S.
We thank Tom Besser for critical reading of the manuscript and Lesley Allison for supplying additional E. coli O157 isolates.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: ZAP Laboratory, Department of Veterinary Pathology, Teviot Place, Edinburgh EH8 9AG, United Kingdom. Phone: 0131-651-1342. Fax: 0131-650-6531. E-mail: dgally{at}ed.ac.uk.
Editor: V. J. DiRita
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
AlHasani, K.,
I. R. Henderson,
H. Sakellaris,
K. Rajakumar,
T. Grant,
J. P. Nataro,
R. Robins Browne, and B. Adler.
2000.
The sigA gene which is borne on the She pathogenicity island of Shigella flexneri 2a encodes an exported cytopathic protease involved in intestinal fluid accumulation.
Infect. Immun.
68:2457-2463 |
| 2. |
Allison, L. J.,
P. E. Carter, and F. M. Thompson-Carter.
2000.
Characterization of a recurrent clonal type of Escherichia coli O157:H7 causing major outbreaks in Scotland.
J. Clin. Microbiol.
38:1632-1635 |
| 3. | Ammon, A., L. R. Petersen, and H. Karch. 1999. A large outbreak of hemolytic uremic syndrome caused by an unusual sorbitol-fermenting strain of Escherichia coli O157:H. J. Infect. Dis. 179:1274-1277[CrossRef][Medline]. |
| 4. | Bastian, S. N., I. Carle, and F. Grimont. 1998. Comparison of 14 PCR systems for the detection and subtyping of stx genes in Shiga-toxin-producing Escherichia coli. Res. Microbiol. 149:457-472[Medline]. |
| 5. |
Beltrametti, F.,
A. U. Kresse, and C. A. Guzman.
1999.
Transcriptional regulation of the esp genes of enterohemorrhagic Escherichia coli.
J. Bacteriol.
181:3409-3418 |
| 6. | Bertin, Y., C. Martin, E. Oswald, and J. P. Girardeau. 1996. Rapid and specific detection of F17-related pilin and adhesin genes in diarrheic and septicemic Escherichia coli strains by multiplex PCR. J. Clin. Microbiol. 34:2921-2928[Abstract]. |
| 7. | Blanco, M., J. E. Blanco, J. Blanco, E. A. Gonzalez, M. P. Alonso, H. Maas, and W. H. Jansen. 1996. Prevalence and characteristics of human and bovine verotoxigenic Escherichia coli strains isolated in Galicia (north-western Spain). Eur. J. Epidemiol. 12:13-19[CrossRef][Medline]. |
| 8. | Blanco, M., J. E. Blanco, J. Blanco, E. A. Gonzalez, A. Mora, C. Prado, L. Fernandez, M. Rio, J. Ramos, and M. P. Alonso. 1996. Prevalence and characteristics of Escherichia coli serotype O157:H7 and other verotoxin-producing E. coli in healthy cattle. Epidemiol. Infect. 117:251-257[Medline]. |
| 9. |
Boerlin, P.,
S. A. McEwen,
F. Boerlin Petzold,
J. B. Wilson,
R. P. Johnson, and C. L. Gyles.
1999.
Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans.
J. Clin. Microbiol.
37:497-503 |
| 10. | Brunder, W., H. Schmidt, M. Frosch, and H. Karch. 1999. The large plasmids of Shiga-toxin-producing Escherichia coli (STEC) are highly variable genetic elements. Microbiology 145:1005-1014[Abstract]. |
| 11. | Brunder, W., H. Schmidt, and H. Karch. 1997. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7, cleaves human coagulation factor V. Mol. Microbiol. 24:767-778[CrossRef][Medline]. |
| 12. |
Burland, V.,
Y. Shao,
N. T. Perna,
G. Plunkett,
H. J. Sofia, and F. R. Blattner.
1998.
The complete DNA sequence and analysis of the large virulence plasmid of Escherichia coli O157:H7.
Nucleic Acids Res.
26:4196-4204 |
| 13. | China, B., F. Goffaux, V. Pirson, and J. Mainil. 1999. Comparison of eae, tir, espA and espB genes of bovine and human attaching and effacing Escherichia coli by multiplex polymerase chain reaction. FEMS Microbiol. Lett. 178:177-182[CrossRef][Medline]. |
| 14. | Cray, W. C., L. A. Thomas, R. A. Schneider, and H. W. Moon. 1996. Virulence attributes of Escherichia coli isolated from dairy heifer feces. Vet. Microbiol. 53:369-374[CrossRef][Medline]. |
| 15. |
DeVinney, R.,
M. Stein,
D. Reinscheid,
A. Abe,
S. Ruschkowski, and B. B. Finlay.
1999.
Enterohemorrhagic Escherichia coli O157:H7 produces Tir, which is translocated to the host cell membrane but is not tyrosine phosphorylated.
Infect. Immun.
67:2389-2398 |
| 16. | Djafari, S., F. Ebel, C. Deibel, S. Kramer, M. Hudel, and T. Chakraborty. 1997. Characterization of an exported protease from Shiga toxin-producing Escherichia coli. Mol. Microbiol. 25:771-784[CrossRef][Medline]. |
| 17. | Ebel, F., C. Deibel, A. U. Kresse, C. A. Guzman, and T. Chakraborty. 1996. Temperature- and medium-dependent secretion of proteins by Shiga toxin-producing Escherichia coli. Infect. Immun. 64:4472-4479[Abstract]. |
| 18. |
Elder, R. O.,
J. E. Keen,
G. R. Siragusa,
G. A. Barkocy-Gallagher,
M. Koohmaraie, and W. W. Laegreid.
2000.
Correlation of enterohemorrhagic Escherichia coli O157 prevalence in feces, hides, and carcasses of beef cattle during processing.
Proc. Natl. Acad. Sci. USA
97:2999-3003 |
| 19. |
Elliott, S. J.,
V. Sperandio,
J. A. Girón,
S. Shin,
J. L. Mellies,
L. Wainwright,
S. W. Hutcheson,
T. K. McDaniel, and J. B. Kaper.
2000.
The locus of enterocyte effacement (LEE)-encoded regulator controls expression of both LEE- and non-LEE-encoded virulence factors in enteropathogenic and enterohemorrhagic Escherichia coli.
Infect. Immun.
68:6115-6126 |
| 20. |
Fagan, P. K.,
M. A. Hornitzky,
K. A. Bettelheim, and S. P. Djordjevic.
1999.
Detection of Shiga-like toxin (stx(1) and stx(2)), intimin (eaeA), and enterohemorrhagic Escherichia coli (EHEC) hemolysin (EHEC hlyA) genes in animal feces by multiplex PCR.
Appl. Environ. Microbiol.
65:868-872 |
| 21. | Foodnet. 2000. Foodborne diseases active surveillance network. 1999 results report. Centers for Disease Control and Prevention, Atlanta, Ga. |
| 22. |
Franck, S. M.,
B. T. Bosworth, and H. W. Moon.
1998.
Multiplex PCR for enterotoxigenic, attaching and effacing, and Shiga toxin-producing Escherichia coli strains from calves.
J. Clin. Microbiol.
36:1795-1797 |
| 23. | Frankel, G., A. D. Phillips, I. Rosenshine, G. Dougan, J. B. Kaper, and S. Knutton. 1998. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol. Microbiol. 30:911-921[CrossRef][Medline]. |
| 24. | Friedberg, D., T. Umanski, Y. A. Fang, and I. Rosenshine. 1999. Hierarchy in the expression of the locus of enterocyte effacement genes of enteropathogenic Escherichia coli. Mol. Microbiol. 34:941-952[CrossRef][Medline]. |
| 25. | Hartland, E. L., M. Batchelor, R. M. Delahay, C. Hale, S. Matthews, G. Dougan, S. Knutton, I. Connerton, and G. Frankel. 1999. Binding of intimin from enteropathogenic Escherichia coli to Tir and to host cells. Mol. Microbiol. 32:151-158[CrossRef][Medline]. |
| 26. |
Henderson, I. R.,
J. Czeczulin,
C. Eslava,
F. Noriega, and J. P. Nataro.
1999.
Characterization of pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli.
Infect. Immun.
67:5587-5596 |
| 27. |
Kim, J.,
J. Nietfeldt, and A. K. Benson.
1999.
Octamer-based genome scanning distinguishes a unique subpopulation of Escherichia coli O157:H7 strains in cattle.
Proc. Natl. Acad. Sci. USA
96:13288-13293 |
| 28. |
Klapproth, J. A.,
I. C. A. Scaletsky,
B. P. McNamara,
L. C. Lai,
C. Malstrom,
S. P. James, and M. S. Donnenberg.
2000.
A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation.
Infect. Immun.
68:2148-2155 |
| 29. |
Knutton, S.,
T. Baldwin,
P. H. Williams, and A. S. McNeish.
1989.
Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli.
Infect. Immun.
57:1290-1298 |
| 30. | Knutton, S., I. Rosenshine, M. J. Pallen, I. Nisan, B. C. Neves, C. Bain, C. Wolff, G. Dougan, and G. Frankel. 1998. A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells. EMBO J. 17:2166-2176[CrossRef][Medline]. |
| 31. | Li, B. G., W. H. Koch, and T. A. Cebula. 1997. Detection and characterization of the fimA gene of Escherichia coli O157:H7. Mol. Cell. Probes 11:397-406[CrossRef][Medline]. |
| 32. | McDaniel, T. K., and J. B. Kaper. 1997. A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. Mol. Microbiol. 23:399-407[CrossRef][Medline]. |
| 33. | Meng, J. H., S. H. Zhao, and M. P. Doyle. 1998. Virulence genes of Shiga toxin-producing Escherichia coli isolated from food, animals and humans. Int. J. Food Microbiol. 45:229-235[CrossRef][Medline]. |
| 34. |
Nataro, J. P., and J. B. Kaper.
1998.
Diarrheagenic Escherichia coli.
Clin. Microbiol. Rev.
11:142-203 |
| 35. |
Perna, N. T.,
G. F. Mayhew,
G. Posfai,
S. Elliott,
M. S. Donnenberg,
J. B. Kaper, and F. R. Blattner.
1998.
Molecular evolution of a pathogenicity island from enterohemorrhagic Escherichia coli O157:H7.
Infect. Immun.
66:3810-3817 |
| 36. | Public Health Laboratory Service. 2000. E. coli O157 disease rates in England. [Online.] Public Health Laboratory Service, London, United Kingdom. http://www.phls.co.uk/facts/Gastro/ecoli/ecoliQua.htm. |
| 37. | Roe, A. J., and D. L. Gally. 2000. Enteropathogenic and enterohaemorrhagic Escherichia coli and diarrhoea. Curr. Opin. Infect. Dis. 13:511-517[CrossRef][Medline]. |
| 38. |
Roe, A. J.,
C. Currie,
D. G. E. Smith, and D. L. Gally.
2001.
Analysis of type 1 fimbriae expression in verotoxigenic Escherichia coli: a comparison between serotypes O157 and O26.
Microbiology
147:145-152 |
| 39. | Savarino, S. J., A. McVeigh, J. Watson, A. Cravioto, J. Molina, P. Echeverria, M. K. Bhan, M. M. Levine, and A. Fasano. 1996. Enteroaggregative Escherichia coli heat-stable enterotoxin is not restricted to enteroaggregative E. coli. J. Infect. Dis. 173:1019-1022[Medline]. |
| 40. | Synge, B., and C. Paiba. 2000. Verocytotoxin-producing E. coli O157. Vet. Rec. 147:27-27[Medline]. |
| 41. |
Wieler, L. H.,
A. Schwanitz,
E. Vieler,
B. Busse,
H. Steinruck,
J. B. Kaper, and G. Baljer.
1998.
Virulence properties of Shiga toxin-producing Escherichia coli (STEC) strains of serogroup O118, a major group of STEC pathogens in calves.
J. Clin. Microbiol.
36:1604-1607 |
| 42. | Yamamoto, T., and P. Exheverria. 1996. Detection of the enteroaggregative Escherichia coli heat-stable enterotoxin 1 gene sequences in enterotoxigenic E. coli strains pathogenic for humans. Infect. Immun. 64:1441-1445[Abstract]. |
| 43. | Yamamoto, T., and I. Taneike. 2000. The sequences of enterohemorrhagic Escherichia coli and Yersinia pestis that are homologous to the enteroaggregative E. coli heat-stable enterotoxin gene: cross-species transfer in evolution. FEBS Lett. 472:22-26[CrossRef][Medline]. |
| 44. | Yamamoto, T., N. Wakisaka, F. Sato, and A. Kato. 1997. Comparison of the nucleotide sequence of enteroaggregative Escherichia coli heat-stable enterotoxin 1 genes among diarrheoa-associated Escherichia coli. FEMS Microbiol. Lett. 147:89-95[CrossRef][Medline]. |
| 45. |
Zhang, W. L.,
M. Bielaszewska,
A. Liesegang,
H. Tschape,
H. Schmidt,
M. Bitzan, and H. Karch.
2000.
Molecular characteristics and epidemiological significance of Shiga toxin-producing Escherichia coli O26 strains.
J. Clin. Microbiol.
38:2134-2140 |
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||